BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 21577086)

  • 1. Combined high-dose radiation therapy and systemic chemotherapy improves survival in patients with newly diagnosed metastatic nasopharyngeal cancer.
    Lin S; Tham IW; Pan J; Han L; Chen Q; Lu JJ
    Am J Clin Oncol; 2012 Oct; 35(5):474-9. PubMed ID: 21577086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors and outcome for nasopharyngeal carcinoma.
    Farias TP; Dias FL; Lima RA; Kligerman J; de Sá GM; Barbosa MM; Gonçalves FB
    Arch Otolaryngol Head Neck Surg; 2003 Jul; 129(7):794-9. PubMed ID: 12874084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group.
    Chua DT; Sham JS; Choy D; Lorvidhaya V; Sumitsawan Y; Thongprasert S; Vootiprux V; Cheirsilpa A; Azhar T; Reksodiputro AH
    Cancer; 1998 Dec; 83(11):2270-83. PubMed ID: 9840526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of failure following radiation with and without chemotherapy in patients with nasopharyngeal carcinoma.
    Fuchs S; Rödel C; Brunner T; Iro H; Niedobitek G; Sauer R; Grabenbauer GG
    Onkologie; 2003 Feb; 26(1):12-8. PubMed ID: 12624512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-metastatic stage IV nasopharyngeal carcinoma patients: analysis of the pattern of relapse and survival.
    Ozyar E; Gurkaynak M; Yildiz F; Atahan IL
    Radiother Oncol; 2004 Jul; 72(1):71-7. PubMed ID: 15236877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic influence of prevertebral space involvement in nasopharyngeal carcinoma.
    Lee CC; Chu ST; Chou P; Lee CC; Chen LF
    Clin Otolaryngol; 2008 Oct; 33(5):442-9. PubMed ID: 18983377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety.
    Wee J; Tan EH; Tai BC; Wong HB; Leong SS; Tan T; Chua ET; Yang E; Lee KM; Fong KW; Tan HS; Lee KS; Loong S; Sethi V; Chua EJ; Machin D
    J Clin Oncol; 2005 Sep; 23(27):6730-8. PubMed ID: 16170180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant chemotherapy followed by concurrent chemo-radiation therapy in locally advanced nasopharyngeal carcinoma.
    Al-Amro A; Al-Rajhi N; Khafaga Y; Memon M; Al-Hebshi A; El-Enbabi A; El-Husseiny G; Radawi A; Belal A; Allam A; El-Sebaie M
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):508-13. PubMed ID: 15890594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment results of 59 young patients with nasopharyngeal carcinoma.
    Selek U; Ozyar E; Ozyigit G; Varan A; Buyukpamukcu M; Atahan IL
    Int J Pediatr Otorhinolaryngol; 2005 Feb; 69(2):201-7. PubMed ID: 15656953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoradiotherapy for locally recurrent nasopharyngeal carcinoma: treatment outcome and prognostic factors.
    Nakamura T; Kodaira T; Tachibana H; Tomita N; Tomoda T; Nakahara R; Inokuchi H; Mizoguchi N; Takada A; Fuwa N
    Jpn J Clin Oncol; 2008 Dec; 38(12):803-9. PubMed ID: 18840881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasopharyngeal carcinoma in childhood and adolescence: concept and preliminary results of the cooperative GPOH study NPC-91. Gesellschaft für Pädiatrische Onkologie und Hämatologie.
    Mertens R; Granzen B; Lassay L; Gademann G; Hess CF; Heimann G
    Cancer; 1997 Sep; 80(5):951-9. PubMed ID: 9307197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential external beam radiotherapy and high-dose-rate intracavitary brachytherapy in T1 and T2 nasopharyngeal carcinoma: an evaluation of long-term outcome.
    Thiagarajan A; Lin K; Tiong CE; Tan LK; Loh TK; Goh BC; Lu JJ
    Laryngoscope; 2006 Jun; 116(6):938-43. PubMed ID: 16735885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of overall survival of nasopharyngeal carcinoma patients treated in ten years at a single institution.
    Gokce T; Unlu I; Akcay C
    J BUON; 2010; 15(1):36-42. PubMed ID: 20414925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of china.
    Chen Y; Liu MZ; Liang SB; Zong JF; Mao YP; Tang LL; Guo Y; Lin AH; Zeng XF; Ma J
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1356-64. PubMed ID: 18472356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment outcome for synchronous locoregional failures of nasopharyngeal carcinoma.
    Chua DT; Wei WI; Sham JS; Cheng AC; Au G
    Head Neck; 2003 Jul; 25(7):585-94. PubMed ID: 12808662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5-fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: a phase II study.
    Hong RL; Sheen TS; Ko JY; Hsu MM; Wang CC; Ting LL
    Br J Cancer; 1999 Aug; 80(12):1962-7. PubMed ID: 10471046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial.
    Chen QY; Wen YF; Guo L; Liu H; Huang PY; Mo HY; Li NW; Xiang YQ; Luo DH; Qiu F; Sun R; Deng MQ; Chen MY; Hua YJ; Guo X; Cao KJ; Hong MH; Qian CN; Mai HQ
    J Natl Cancer Inst; 2011 Dec; 103(23):1761-70. PubMed ID: 22056739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation and chemotherapy combination for nasopharyngeal carcinoma in children: Radiotherapy dose adaptation after chemotherapy response to minimize late effects.
    Orbach D; Brisse H; Helfre S; Klijanienko J; Bours D; Mosseri V; Rodriguez J
    Pediatr Blood Cancer; 2008 Apr; 50(4):849-53. PubMed ID: 17973328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.